C-MER medical maintains share capital, repurchases shares

As of August 31, 2025, C-MER Medical Holdings Limited maintained its authorized share capital at 8,000,000,000 ordinary shares with a par value of HK$0.1, totaling HK$800,000,000. The total number of issued shares remained at 1,255,560,870, with 1,246,830,870 shares outstanding (excluding treasury shares) and 8,730,000 treasury shares.

The company's Post-IPO Share Option Scheme reported 200,000 options outstanding at an exercise price of HK$7.73, with 200,000 new shares issued during the month under this scheme. The total number of shares that may be issued upon exercise of all share options is 92,120,000.

C-MER Medical also disclosed share repurchase activities. A total of 23,218,000 shares were repurchased for cancellation between July 2024 and May 2025, pending cancellation as of the month's close. Additionally, 8,730,000 shares were repurchased as treasury shares from May 2025 to July 2025.